Statistical Trends in Pharmaceutical Research for Poor Countries
Published By: CIPIH on eSS | Published Date: April, 20 , 2005Introducing patent rights in developing country markets might stimulate greater R and D investment targeting their specific health needs – areas long neglected. This paper examines this argument using statistical data and survey evidence. We identify a set of diseases where 99 per cent of the burden is estimated to fall in lower income countries. Because science gaps and market potential will influence R and D priorities, this group is broke into a subset that already have low-cost and effect treatments, and those that to not.
Author(s): Peter Lanjouw, Jean O Lanjouw | Posted on: Nov 26, 2009 | Views(1253) | Download (793)